Advanced Cell Technology (ACTC.OB) Orphan Drug Designation from EMA for hESC-Derived RPE Cells
March 10th, 2011
No comments
The European Medicines Agency (EMA) announced Orphan Drug Designation (ODD).
Categories: European Medicines Agency (EMA), NASDAQ: ACTC.OB, Stem Cell Research
